Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
12,41 USD | +6,16 % | +2,99 % | +135,93 % |
17/04 | Stoke Therapeutics nombra a Jason Hoitt Director Comercial | CI |
28/03 | Actualización del sector: Los valores del sector sanitario avanzan el jueves antes de la comercialización | MT |
Resumen de negocios
Número de empleados: 110
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antisense Oligonucleotide
100,0
%
| 12 | 100,0 % | 9 | 100,0 % | -29,22 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 12 | 100,0 % | 9 | 100,0 % | -29,22 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Edward Kaye
CEO | Chief Executive Officer | 75 | 01/10/17 |
Isabel Aznarez
FOU | Founder | 52 | 01/06/14 |
Stephen Tulipano
DFI | Director of Finance/CFO | 65 | 01/03/19 |
Barry Ticho
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/10/17 |
Huw Nash
COO | Chief Operating Officer | 57 | 01/10/14 |
Eric Rojas
IRC | Investor Relations Contact | - | - |
Jonathan Allan
LAW | General Counsel | - | - |
Shamim Ruff
LAW | General Counsel | 64 | 01/12/18 |
Joan Wood
HRO | Human Resources Officer | - | 16/10/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 01/09/15 |
Edward Kaye
CEO | Chief Executive Officer | 75 | 01/10/17 |
Seth Harrison
CHM | Chairman | 63 | 01/07/15 |
Ian Smith
BRD | Director/Board Member | 58 | 19/09/23 |
Garry Menzel
BRD | Director/Board Member | 59 | 13/08/20 |
Julie Smith
BRD | Director/Board Member | 53 | 04/06/20 |
Director/Board Member | 52 | 14/06/19 | |
Arthur Tzianabos
BRD | Director/Board Member | 60 | 17/09/18 |
Adrian Krainer
FOU | Founder | 65 | 01/06/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 52 117 499 | 49 727 994 ( 95,42 %) | 0 | 95,42 % |
Información de la empresa
Stoke Therapeutics, Inc.
45 Wiggins Avenue
01730, Bedford
+781 430 8200
http://www.stoketherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+135,93 % | 647 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción STOK
- Empresa Stoke Therapeutics, Inc.